AUPH
Aurinia Pharmaceuticals Inc
16.40$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +73.8% | -33.5% | +486.8% | +125.0% | -35.7% | -83.4% | -7.5% | +199.1% | -33.7% | +66.1% | +4.5% | -15.6% | -72.9% | +563.9% | -84.6% | -70.7% | -15.5% | -26.4% | +142.8% | +10.2% | -31.3% | +15,660.4% | -9.0% | +193.9% | +31.0% | +34.0% | +20.4% | |
| – | +30.4% | +0.2% | +50.6% | -33.1% | +112.1% | +10.2% | +28.6% | -71.0% | +75.9% | +101.4% | -72.8% | -91.1% | +263.0% | -75.0% | -98.0% | +3,839.6% | -67.6% | -66.7% | -75.0% | +4,138,100.0% | +27.8% | -4.8% | -97.8% | +419.2% | +149.8% | +99.7% | +15.6% | |
| – | +160.8% | -67.3% | +1,823.4% | +162.9% | -31.8% | -83.4% | -7.5% | +148.4% | -56.1% | +37.2% | +97.3% | -3.1% | -78.0% | +723.2% | -84.5% | -74.6% | -7.5% | -24.2% | +147.9% | -9,865.9% | – | +15,660.4% | -11.2% | +188.4% | +25.7% | +28.2% | +21.0% | |
| – | -0.4% | +235.1% | +76.0% | -15.5% | +28.4% | +48.2% | +43.8% | -2.3% | +56.3% | -61.5% | -33.1% | -47.9% | -12.9% | +58.5% | -64.9% | +371.2% | +75.4% | -9.1% | +133.5% | +22.0% | +27.8% | -4.8% | +1.6% | -12.0% | +10.3% | -58.1% | +56.4% | |
| – | -25.5% | +74.1% | +72.2% | +62.6% | +67.8% | -5.8% | +24.6% | -36.7% | -7.8% | -20.5% | -20.5% | -9.5% | -16.0% | +42.2% | -42.8% | +208.8% | -9.1% | +11.3% | +73.5% | +13.0% | +63.4% | +335.5% | +76.2% | +14.5% | -0.7% | -19.0% | -37.6% | |
| – | -35.1% | +266.2% | +69.5% | +8.2% | +47.8% | +29.4% | +28.8% | -13.9% | +37.8% | -53.4% | -28.1% | -32.6% | -14.7% | +61.3% | -57.0% | +252.0% | +35.8% | -3.4% | +106.6% | +19.2% | +61.2% | +69.2% | +45.9% | +6.5% | +5.5% | -16.4% | -31.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | -100.0% | – | -29.6% | -47.4% | +497.9% | +21.7% | -98.8% | -91.8% | +10,215.7% | +1.9% | -70.9% | +66.7% | -46.0% | +2,500.0% | +218.2% | -98.3% | +13,471.8% | -90.0% | +867.5% | -45.8% | +74.2% | -10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,432.7% | |
| – | – | – | +304.1% | +29.8% | +76.2% | -97.4% | -74.1% | -199.6% | – | +111.5% | +38.8% | -90.2% | +3,884.3% | -98.6% | -7,075.2% | – | -16,676.7% | – | +4,873.8% | -99.7% | +97.3% | -165.3% | – | +140.5% | -69.9% | +207.8% | -10,303.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4,893.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +302.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.